BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37875556)

  • 21. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
    Zhao S; Zhu Y; Liu H; He X; Xie J
    J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A CD8
    Sun S; Zhi Z; Su Y; Sun J; Li Q
    Front Immunol; 2022; 13():1039565. PubMed ID: 36341357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
    Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
    Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
    Liang L; Mai S; Mai G; Chen Y; Liu L
    Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of tumor microenvironment infiltration and the identification of angiogenesis-related subgroups in skin cutaneous melanoma.
    Li J; Ren H; Huai H; Li J; Xie P; Li X
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7259-7273. PubMed ID: 36912943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma.
    Li AA; Zhang Y; Tong WL; Chen JW; Huang SH; Liu JM; Liu ZL
    Int J Gen Med; 2022; 15():6145-6163. PubMed ID: 35855761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM.
    Liu Y; Zhang H; Mao Y; Shi Y; Wang X; Shi S; Hu D; Liu S
    Front Immunol; 2023; 14():1094042. PubMed ID: 37304304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin cutaneous melanoma properties of immune-related lncRNAs identifying potential prognostic biomarkers.
    Ma Y; Wang N; Yang S
    Aging (Albany NY); 2022 Mar; 14(7):3030-3048. PubMed ID: 35361740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of Prognostic Risk Model of Patients with Skin Cutaneous Melanoma Based on TCGA-SKCM Methylation Cohort.
    Yu X; Cong P; Wei W; Zhou Y; Bao Z; Hou H
    Comput Math Methods Med; 2022; 2022():4261329. PubMed ID: 36060650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients.
    Zhang X; Ding C; Zhao Z
    Adv Med Sci; 2022 Sep; 67(2):364-378. PubMed ID: 36155341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unveiling the link between inflammasomes and skin cutaneous melanoma: Insights into expression patterns and immunotherapy response prediction.
    Sheng Y; Liu J; Zhang M; Zheng S
    Math Biosci Eng; 2023 Nov; 20(11):19912-19928. PubMed ID: 38052629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment.
    Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B
    Front Genet; 2022; 13():917007. PubMed ID: 35899194
    [No Abstract]   [Full Text] [Related]  

  • 38. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma.
    Sun S; Zhang G; Zhang L
    Front Cell Dev Biol; 2021; 9():790047. PubMed ID: 35186949
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
    Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
    J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the ageing-related prognostic gene signature, and the associated regulation axis in skin cutaneous melanoma.
    Tian C; Liu S; Huo R
    Sci Rep; 2023 Jan; 13(1):24. PubMed ID: 36631465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.